BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22624766)

  • 1. Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw.
    Hewson I; Syme D; Bruscino-Raiola F
    Aust Dent J; 2012 Jun; 57(2):227-30. PubMed ID: 22624766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-related osteonecrosis of the jaws--a case report.
    Kamoh AK; Ogle O
    Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal cross-linking telopeptide as a serologic marker for bisphosphonate-related osteonecrosis of the jaw: review of 2 cases.
    Pasoff M
    J Can Dent Assoc; 2013; 79():d51. PubMed ID: 23920073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
    Merigo E; Manfredi M; Meleti M; Corradi D; Vescovi P
    J Oral Pathol Med; 2005 Nov; 34(10):613-7. PubMed ID: 16202082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
    Gallego L; Junquera L
    Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw: a case report and narrative review.
    Thumbigere-Math V; Gopalakrishnan R; Michalowicz BS
    Northwest Dent; 2013; 92(1):12-8. PubMed ID: 23516715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental investigation of relationship between trauma and bisphosphonate-related osteonecrosis.
    Agaçayak KS; Yuksel H; Atilgan S; Koparal M; Uçan MC; Ozgöz M; Yaman F; Atalay Y; Acikan I
    Niger J Clin Pract; 2014; 17(5):559-64. PubMed ID: 25244263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate-induced osteonecrosis of the jaw 32 months after interruption of zoledronate in a patient with multiple myeloma.
    Del Conte A; Bernardeschi P; La Ferla F; Turrisi G; D'Alessandro M; Montagnani F; Fiorentini G
    J Oral Maxillofac Surg; 2010 May; 68(5):1179-82. PubMed ID: 20185222
    [No Abstract]   [Full Text] [Related]  

  • 9. Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
    Infante Cossío P; Cabezas Macián A; Pérez Ceballos JL; Palomino Nicas J; Gutiérrez Pérez JL
    Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E52-7. PubMed ID: 18167482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
    Dimitrakopoulos I; Magopoulos C; Karakasis D
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy.
    Melo MD; Obeid G
    J Can Dent Assoc; 2005 Feb; 71(2):111-3. PubMed ID: 15691429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs).
    Holzinger D; Seemann R; Klug C; Ewers R; Millesi G; Baumann A; Wutzl A
    Oral Oncol; 2013 Jan; 49(1):66-70. PubMed ID: 22892237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris.
    Maurer P; Sandulescu T; Kriwalsky MS; Rashad A; Hollstein S; Stricker I; Hölzle F; Kunkel M
    Int J Oral Maxillofac Surg; 2011 Mar; 40(3):285-91. PubMed ID: 21163624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.
    Yoshiga D; Sasaguri M; Matsuo K; Kokuryou S; Habu M; Oda M; Kodama M; Tsurushima H; Sakaguchi O; Sakurai T; Tanaka J; Morimoto Y; Yoshioka I; Tominaga K
    Osteoporos Int; 2015 Jul; 26(7):1997-2006. PubMed ID: 26037792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction.
    Saia G; Blandamura S; Bettini G; Tronchet A; Totola A; Bedogni G; Ferronato G; Nocini PF; Bedogni A
    J Oral Maxillofac Surg; 2010 Apr; 68(4):797-804. PubMed ID: 20307765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-associated osteonecrosis of the jaw: a six-year history of a case.
    Hewson ID
    N Z Dent J; 2011 Sep; 107(3):97-100. PubMed ID: 21957837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome.
    Fortuna G; Ruoppo E; Pollio A; Aria M; Adamo D; Leuci S; Orabona GD; Mignogna MD
    J Oral Pathol Med; 2012 Mar; 41(3):222-8. PubMed ID: 22092390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of bisphosphonate-related osteonecrosis of the jaw in a patient who had received intravenous bisphosphonates].
    Ishikawa T
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):225-7. PubMed ID: 24743202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.